A prospective, multicenter, open-label single arm study evaluating the safety and efficacy of selective internal radiation therapy SIRT using SIR-Spheres Y-90 resin microspheres on duration of response DoR and objective response rate ORR in unresectable hepatocellular carcinoma HCC patients
DOORwaY90 Study
A Phase III, Randomized, Controlled, Multicenter, Open-label Study to Compare Tivozanib
in Combination with Nivolumab to Tivozanib Monotherapy in Subjects with Renal Cell Carcinoma Who
Have Progressed Following One or Two Lines of Therapy Where One Line has an Immune Checkpoint
Inhibitor 257305
An Open label, Phase I/II study to evaluate the safety and efficacy of Tenalisib RP6530, a novel PI3K ?/? dual inhibitor given in combination with a histone deacetylase HDAC inhibitor, Romidepsin in adult patients with relapsed/refractory T-cell Lymphoma